SlowBull
The Business Brief TUESDAY, 8 SEPTEMBER 2026
← All stories
Markets

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

1 source ·1 article ·1h ago Avis Budget

Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly pediatric cancer into mid-stage testing.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·1h ago

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly pediatric cancer into mid-stage testing.